Yang De Marinis is currently an assistant professor at the Department of Clinical Sciences, Lund University. Dr. Yang De Marinis received her PhD degree in 2010 at Lund University on electrophysiology. She was then a Postdoc fellow between 2010-2015 in the lab of world-leading geneticist Prof Leif Groop at Lund University. Currently her research team is specialized in multi-discipline approaches on epigenetics, genetics, molecular biology and deep machine learning. She led several multi-center projects, and published more than 20 peer-reviewed and popular science articles with more than 700 citations.
In this EASD lecture, she will present a novel discovery on a protein in the blood circulation that predicts and mediates type 2 diabetes. Previous large cohort studies have shown that it is possible to reduce the incidence of diabetes in persons at high risk by lifestyle intervention or medication if disease risk can be predicted early enough. This study led by Dr. Yang De Marinis introduced a potential new method of type 2 diabetes early screening. Detailed investigations were performed on 8,000 individuals from eight cohorts across eight countries; and applied epidemiology analysis, artificial intelligence-deep machine learning, genome-wide association studies, human cell model in vitro validation and magnetic resonance tomography.
- The EASD attracts scientists and clinicians on diabetes research and care from all over the world, and is a great forum for presenting these novel findings, she says.
If you want to learn more, listen to Yang De Marinis on Thursday September 19, 10:15 - 11:45, during the session "Spotlights on prediction and prevention of type 2 diabetes", Trueta Hall
Title: Follistatin-a circulating biomarker for type 2 diabetes